Skip to main content
Clinical Trials/NCT01830998
NCT01830998UnknownNot Applicable

Study of Cognitive Dysfunction and Diabetes

Wuhan General Hospital of Guangzhou Military Command3 sites in 1 country400 target enrollmentStarted: January 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
400
Locations
3
Primary Endpoint
MMSE Olfactory function dementia

Study Overview

Brief Summary

The rate of cognitive decline due to ageing is increased 1.5-fold to 2.0-fold in individuals with type 2 diabetes.There are no established specific treatment measures to prevent or ameliorate cognitive impairments in patients with diabetes. we want to detecte early clinical dementia in diabete.

Detailed Description

Clinically relevant cognitive decrements in relation to diabetes mainly occur during two crucial periods in life: the period of brain development in childhood, and the period when the brain undergoes neurodegenerative changes associated with ageing.Potential leads for treatment are to optimise glycaemic control and avoid and treat vascular risk factors.we want to detecte early clinical dementia in diabete by MMSE and Olfactory function.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
50 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with type 2 diabetes(Age>50 years)

Exclusion Criteria

  • with stroke or other complications.

Outcomes

Primary Outcomes

MMSE Olfactory function dementia

Time Frame: 2 years

MMSE,Olfactory function and PET(fMRI) were observed.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Wuhan General Hospital of Guangzhou Military Command
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

zhipeng xu

doctor

Wuhan General Hospital of Guangzhou Military Command

Study Sites (3)

Loading locations...

Similar Trials